FDA approves Abbott's LCx gonorrhoea test:
This article was originally published in Clinica
Abbott Laboratories has received US FDA approval for its gonorrhoea test for use with the company's LCx Probe System. The new test, based on Abbott's ligase chain reaction amplification technology, will allow laboratories to detect gonorrhoea in urine samples, as well as with swabs. It can be used in tandem with the company's LCx chlamydia test. Current tests for gonorrhoea, which is often asymptomatic and underdiagnosed, are "invasive, uncomfortable, time-consuming and labour-intensive", says Abbott. As a result they are not commonly used unless patients believe they have been infected.